[
  {
    "title": "Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million",
    "link": "https://www.globenewswire.com/news-release/2026/02/21/3242195/0/en/Rakovina-Therapeutics-Announces-Upsized-Financing-Up-to-2-0-Million.html",
    "description": "<p align=\"center\"><em>Proposed $1.0 Million Convertible Debenture and Warrant Financing and\u00a0</em><br><em>Concurrent Common Share Private Placement Up to $1.0 Million </em><br><em>Intended to Support Near-Term Operations</em></p>",
    "pubDate": "Sat, 21 Feb 2026 00:50 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Fortera",
      "Asimov",
      "Profluent"
    ],
    "categories": [
      "funding",
      "product"
    ]
  },
  {
    "title": "VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025",
    "link": "https://www.globenewswire.com/news-release/2026/02/21/3242192/0/en/VERSES-Announces-Filing-of-Quarterly-Report-on-Form-10-Q-for-the-Three-and-Nine-Months-Ended-December-31-2025.html",
    "description": "<p>VANCOUVER, British Columbia, Feb.  20, 2026  (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (\"VERSES\" or the \"Company\"), a cognitive computing company pioneering next-generation agentic software systems today announced that it has filed its Quarterly Report on Form 10-Q (\u201cQuarterly Report\u201d) for the three months and nine months ended December 31, 2025, with the U.S. Securities and Exchange Commission (\u201cSEC\u201d).</p>",
    "pubDate": "Sat, 21 Feb 2026 00:11 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "K2 Capital Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing on February 25, 2026  \u00a0",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242185/0/en/K2-Capital-Acquisition-Corp-Announces-the-Separate-Trading-of-its-Class-A-Ordinary-Shares-and-Rights-Commencing-on-February-25-2026.html",
    "description": "<p align=\"justify\">NEW YORK, Feb.  20, 2026  (GLOBE NEWSWIRE) -- K2 Capital Acquisition Corp. (the \"Company\") today announced that, commencing on February 25, 2026, holders of the 13,800,000 units (the \u201cUnits\u201d) sold in the Company\u2019s initial public offering (the \u201cOffering\u201d), including Units sold upon full exercise of the underwriters\u2019 over-allotment option, may elect to separately trade the Class A ordinary shares and rights included in the Units. Any Units not separated will continue to trade on",
    "pubDate": "Fri, 20 Feb 2026 23:00 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Flexport"
    ],
    "categories": [
      "product",
      "ipo"
    ]
  },
  {
    "title": "Helios Fairfax Partners Corporation Closes Amendment to Credit Facility",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242181/0/en/Helios-Fairfax-Partners-Corporation-Closes-Amendment-to-Credit-Facility.html",
    "description": "<p align=\"center\"><em>NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES</em></p>",
    "pubDate": "Fri, 20 Feb 2026 22:30 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242180/0/en/Psyence-BioMed-Announces-Exercise-of-Put-Option-by-PsyLabs-and-Strategic-Equity-Investment.html",
    "description": "<p align=\"justify\">NEW YORK, Feb.  20, 2026  (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (\u201c<strong>Psyence BioMed</strong>\u201d or the \u201c<strong>Company</strong>\u201d), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced that Psyence Labs Ltd., a leading developer and manufacturer of pharmaceutical-grade psychedelic compounds (\"<strong>PsyLabs</strong>\") has exercised its rights under a previously disclosed pu",
    "pubDate": "Fri, 20 Feb 2026 22:20 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Zipline",
      "Kinova Robotics"
    ],
    "categories": [
      "funding",
      "product"
    ]
  },
  {
    "title": "Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242179/0/en/Constellation-Software-Inc-Announces-Change-to-the-Date-of-the-Conference-Call-to-Discuss-Fourth-Quarter-Results.html",
    "description": "<p align=\"justify\">TORONTO, Feb.  20, 2026  (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) announced on February 17, 2026 that it would be holding its fourth quarter conference call on March 10, 2026 at 8:00 am. Constellation has changed the date of the conference call to March 9, 2026 at 8:30 am.</p>",
    "pubDate": "Fri, 20 Feb 2026 22:16 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242177/0/en/Iovance-Biotherapeutics-Reports-Inducement-Grants-under-NASDAQ-Listing-Rule-5635-c-4.html",
    "description": "<p>SAN CARLOS, Calif., Feb.  20, 2026  (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (\"Iovance\" or the \u201cCompany\u201d), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (\u201cTIL\u201d) therapies for patients with cancer, today announced that on February 19, 2026 (the \u201cDate of Grant\u201d), the Company approved the grant of inducement stock options covering an aggregate of 3,600 shares of Iovance\u2019s common stock to two new, n",
    "pubDate": "Fri, 20 Feb 2026 22:15 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Focused Energy",
      "Fortera",
      "Asimov",
      "Profluent"
    ],
    "categories": []
  },
  {
    "title": "Equinox Gold Announces Filing of 2025 Audited Financial Statements",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242175/0/en/Equinox-Gold-Announces-Filing-of-2025-Audited-Financial-Statements.html",
    "description": "Equinox Gold has filed its audited financial statements and MD&A for the three months and year ended December 31, 2025.",
    "pubDate": "Fri, 20 Feb 2026 22:10 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares ",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242170/8624/en/Trinity-Biotech-Receives-Non-Compliance-Notice-Regarding-Nasdaq-Global-Select-Requirement-for-Minimum-Market-Value-of-Publicly-Held-Shares.html",
    "description": "<p align=\"justify\">DUBLIN, Feb.  20, 2026  (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice on February 19, 2026 from the Nasdaq Stock Market LLC (\u201cNasdaq\u201d) that the Company no longer meets the requirement in Nasdaq Listing Rule 5450(b) that listed securities maintain a minimum market value of publicly held shares (\u201cMVPHS\u201d) of $15,000,000,",
    "pubDate": "Fri, 20 Feb 2026 22:00 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Mammoth Biosciences",
      "Focused Energy",
      "Tempus AI",
      "Oxford Nanopore Technologies",
      "Neko Health"
    ],
    "categories": [
      "ipo"
    ]
  },
  {
    "title": "Andrew Peller Limited Announces Change to its Board of Directors",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242171/0/en/Andrew-Peller-Limited-Announces-Change-to-its-Board-of-Directors.html",
    "description": "<p align=\"justify\">GRIMSBY, Ontario, Feb.  20, 2026  (GLOBE NEWSWIRE) -- Andrew Peller Limited (TSX: ADW.A / ADW.B) (\u201cAPL\u201d or the \u201cCompany\u201d) announced today that W. James Westlake has resigned from the Company's board of directors to focus on other commitments.</p>",
    "pubDate": "Fri, 20 Feb 2026 22:00 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "AirBoss to Release 4th Quarter and FY 2025 Earnings on March 4, 2026",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242172/0/en/AirBoss-to-Release-4th-Quarter-and-FY-2025-Earnings-on-March-4-2026.html",
    "description": "<p align=\"justify\">NEWMARKET, Ontario, Feb.  20, 2026  (GLOBE NEWSWIRE) -- AirBoss of America Corp. (TSX: BOS) (OTCQX:ABSSF) (the \u201cCompany\u201d or \u201cAirBoss\u201d) today announced that it will release its fourth quarter and unaudited full year 2025 results after markets close on March 4, 2026. The release will be followed by a conference call to discuss the results on Thursday, March 5, 2026, at 9:00 am ET. The Company will file its audited annual consolidated financial statements and related management\u2019s",
    "pubDate": "Fri, 20 Feb 2026 22:00 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Navient declares first quarter common stock dividend",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242173/30821/en/Navient-declares-first-quarter-common-stock-dividend.html",
    "description": "<p align=\"left\">HERNDON, Va., Feb.  20, 2026  (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) announced that its board of directors approved a 2026 first quarter dividend of $0.16 per share on the company's common stock.</p>",
    "pubDate": "Fri, 20 Feb 2026 22:00 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242166/0/en/Bel-Fuse-Inc-Announces-Regular-Quarterly-Cash-Dividend-on-its-Class-A-and-Class-B-Shares.html",
    "description": "<p align=\"justify\">WEST ORANGE, N.J., Feb.  20, 2026  (GLOBE NEWSWIRE) -- <strong>BEL FUSE INC. (NASDAQ:BELFA) and (NASDAQ:BELFB)</strong> today announced that its Board of Directors has declared regular quarterly cash dividends of $0.06 per share on the Company's Class A common shares and $0.07 per share on the Company's Class B common shares.</p>",
    "pubDate": "Fri, 20 Feb 2026 21:49 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242156/20739/en/Ultragenyx-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html",
    "description": "<p align=\"left\">NOVATO, Calif., Feb.  20, 2026  (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 22,917 restricted stock units of the company\u2019s common stock to six newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company\u2019s board of directors and granted under ",
    "pubDate": "Fri, 20 Feb 2026 21:30 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Focused Energy",
      "Fortera"
    ],
    "categories": [
      "contract",
      "hiring"
    ]
  },
  {
    "title": "Founder Group Limited Receives NASDAQ Notification Regarding Minimum Publicly Held Shares Deficiency",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242157/0/en/Founder-Group-Limited-Receives-NASDAQ-Notification-Regarding-Minimum-Publicly-Held-Shares-Deficiency.html",
    "description": "<p align=\"justify\">SELANGOR, Malaysia, Feb.  20, 2026  (GLOBE NEWSWIRE) -- Founder Group Limited (Nasdaq: FGL) (\u201cFGL\u201d or the \u201cCompany\u201d), announced today that on February 17, 2026, the Company received a letter from the Listing Qualifications Department of Nasdaq Stock Market LLC (\u201cNasdaq\u201d) notifying the Company that since it no longer meets the minimum 500,000 publicly held shares requirement under Nasdaq Listing Rule 5550(a)(4) for the Nasdaq Capital Market, it no longer complies with the Listi",
    "pubDate": "Fri, 20 Feb 2026 21:30 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "iPower Reports Fiscal Q2 2026 Results and Completes Strategic Operating Reset",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242159/0/en/iPower-Reports-Fiscal-Q2-2026-Results-and-Completes-Strategic-Operating-Reset.html",
    "description": "<p align=\"justify\">RANCHO CUCAMONGA, Calif., Feb.  20, 2026  (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq: IPW) (\u201ciPower\u201d or the \u201cCompany\u201d) today reported financial results for the fiscal second quarter ended December 31, 2025. Revenue was <strong>$7.1 million</strong>, reflecting the Company\u2019s <strong>deliberate supply chain restructuring and transition to predominantly U.S.-based sourcing during the quarter</strong>, while gross profit was <strong>$3.1 million</strong> and gross margin remained str",
    "pubDate": "Fri, 20 Feb 2026 21:30 GMT",
    "source": "globenewswire_all",
    "companies": [
      "The Boring Company",
      "Bronco AI",
      "Fortastra"
    ],
    "categories": [
      "funding",
      "milestone",
      "ipo"
    ]
  },
  {
    "title": "Parex Resources Announces Nomination of Six Directors to GeoPark\u2019s Board ",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242160/0/en/Parex-Resources-Announces-Nomination-of-Six-Directors-to-GeoPark-s-Board.html",
    "description": "<p align=\"justify\">CALGARY, Alberta, Feb.  20, 2026  (GLOBE NEWSWIRE) -- Parex Resources Inc. (\u201cParex\u201d or the \u201cCompany\u201d) (TSX: PXT), which has an approximate 11.8% ownership position in GeoPark Limited (\u201cGeoPark\u201d) (NYSE: GPRK), announced today that it has nominated six highly qualified director candidates for election to GeoPark\u2019s Board of Directors (the \u201cGeoPark Board\u201d) at its upcoming 2026 Annual Meeting of Shareholders (the \u201cAnnual Meeting\u201d). Each of the nominees is independent of both GeoPar",
    "pubDate": "Fri, 20 Feb 2026 21:30 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Xanadu to Host Analyst Day on March 4, 2026",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242161/0/en/Xanadu-to-Host-Analyst-Day-on-March-4-2026.html",
    "description": "<p>TORONTO, Feb.  20, 2026  (GLOBE NEWSWIRE) -- Xanadu Quantum Technologies Inc. (\u201cXanadu\u201d), a leading photonic quantum computing company, today announced that it will host an Analyst Day on Wednesday, March 4, 2026 at 9:00 am ET<strong>.</strong></p>",
    "pubDate": "Fri, 20 Feb 2026 21:30 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Rocket Lab",
      "Atom Computing",
      "Conductor Quantum",
      "PsiQuantum",
      "IonQ",
      "Rigetti Computing",
      "QuEra Computing",
      "Oxford Quantum Circuits",
      "planqc",
      "Pasqal",
      "Alice & Bob",
      "IQM Quantum Computers",
      "QuantWare",
      "Quantum Machines",
      "Xanadu Quantum Technologies",
      "Quantum Brilliance",
      "D-Wave Quantum",
      "Photonic Inc",
      "Nord Quantique",
      "Q-CTRL",
      "Quantinuum",
      "QuiX Quantum"
    ],
    "categories": []
  },
  {
    "title": "Abony Acquisition Corp. I Announces Closing of $230 Million Initial Public Offering Including Exercise of Underwriter\u2019s Over-Allotment Option in Full",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242155/0/en/Abony-Acquisition-Corp-I-Announces-Closing-of-230-Million-Initial-Public-Offering-Including-Exercise-of-Underwriter-s-Over-Allotment-Option-in-Full.html",
    "description": "<p align=\"justify\">AUSTIN, TX, Feb.  20, 2026  (GLOBE NEWSWIRE) --  Abony Acquisition Corp. I (Nasdaq: AACOU) (the \u201cCompany\u201d) today announced the closing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the underwriter of its over-allotment option in full, at a public offering price of $10.00 per unit. Each unit sold in the offering consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole ",
    "pubDate": "Fri, 20 Feb 2026 21:20 GMT",
    "source": "globenewswire_all"
  },
  {
    "title": "Electra Upsizes At-The-Market Offering",
    "link": "https://www.globenewswire.com/news-release/2026/02/20/3242154/0/en/Electra-Upsizes-At-The-Market-Offering.html",
    "description": "<p align=\"justify\">TORONTO, Feb.  20, 2026  (GLOBE NEWSWIRE) -- <strong>Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM)</strong> (\u201cElectra\u201d or the \u201cCompany\u201d) has announced that it has upsized its previously announced At the Market Offering Program (the \u201cATM\u201d), pursuant to which the Company may offer and sell, at its discretion and from time to time, through H.C. Wainwright & Co., LLC (\u201cWainwright\u201d), common shares in the capital of the Company (the \u201cCommon Shares\u201d) having an",
    "pubDate": "Fri, 20 Feb 2026 21:20 GMT",
    "source": "globenewswire_all",
    "companies": [
      "Impulse Labs",
      "Space Forge"
    ],
    "categories": []
  }
]